IL195532A0 - Combination preparations comprising slv308 and a l-dopa - Google Patents
Combination preparations comprising slv308 and a l-dopaInfo
- Publication number
- IL195532A0 IL195532A0 IL195532A IL19553208A IL195532A0 IL 195532 A0 IL195532 A0 IL 195532A0 IL 195532 A IL195532 A IL 195532A IL 19553208 A IL19553208 A IL 19553208A IL 195532 A0 IL195532 A0 IL 195532A0
- Authority
- IL
- Israel
- Prior art keywords
- slv308
- dopa
- combination preparations
- preparations
- combination
- Prior art date
Links
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81405106P | 2006-06-16 | 2006-06-16 | |
| EP06115583 | 2006-06-16 | ||
| PCT/EP2007/055955 WO2007144421A1 (en) | 2006-06-16 | 2007-06-15 | Combination preparations comprising slv308 and a l-dopa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL195532A0 true IL195532A0 (en) | 2009-09-01 |
Family
ID=38434785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL195532A IL195532A0 (en) | 2006-06-16 | 2008-11-26 | Combination preparations comprising slv308 and a l-dopa |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2035002A1 (en) |
| JP (1) | JP2009539941A (en) |
| KR (1) | KR20090031908A (en) |
| AU (1) | AU2007259255A1 (en) |
| CA (1) | CA2654719A1 (en) |
| EA (1) | EA015073B1 (en) |
| IL (1) | IL195532A0 (en) |
| MY (1) | MY148457A (en) |
| NO (1) | NO20090164L (en) |
| WO (1) | WO2007144421A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0027020D0 (en) | 2000-11-03 | 2000-12-20 | Univ Manchester | Treatment of movement disorders |
| US20090247537A1 (en) * | 2008-03-25 | 2009-10-01 | William Dale Overfield | Methods for preventing or treating bruxism using dopaminergic agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7596407B2 (en) * | 2004-03-26 | 2009-09-29 | Solvay Pharmaceuticals, B.V. | Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds |
| CA2581143C (en) * | 2004-09-21 | 2015-03-31 | Shandong Luye Pharmaceutical Co., Ltd. | Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof |
| RU2394821C2 (en) * | 2005-08-22 | 2010-07-20 | Солвей Фармасьютикал Б.В. | N-oxides as prodrug of piperazine and piperidine derivatives |
-
2007
- 2007-06-15 MY MYPI20085078A patent/MY148457A/en unknown
- 2007-06-15 CA CA002654719A patent/CA2654719A1/en not_active Abandoned
- 2007-06-15 AU AU2007259255A patent/AU2007259255A1/en not_active Abandoned
- 2007-06-15 KR KR1020097001024A patent/KR20090031908A/en not_active Application Discontinuation
- 2007-06-15 EP EP07730193A patent/EP2035002A1/en not_active Withdrawn
- 2007-06-15 WO PCT/EP2007/055955 patent/WO2007144421A1/en active Search and Examination
- 2007-06-15 EA EA200970021A patent/EA015073B1/en not_active IP Right Cessation
- 2007-06-15 JP JP2009514809A patent/JP2009539941A/en active Pending
-
2008
- 2008-11-26 IL IL195532A patent/IL195532A0/en unknown
-
2009
- 2009-01-12 NO NO20090164A patent/NO20090164L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2035002A1 (en) | 2009-03-18 |
| MY148457A (en) | 2013-04-30 |
| CA2654719A1 (en) | 2007-12-21 |
| KR20090031908A (en) | 2009-03-30 |
| AU2007259255A1 (en) | 2007-12-21 |
| EA200970021A1 (en) | 2009-06-30 |
| JP2009539941A (en) | 2009-11-19 |
| WO2007144421A1 (en) | 2007-12-21 |
| EA015073B1 (en) | 2011-04-29 |
| NO20090164L (en) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2042138A4 (en) | Patch and patch preparation | |
| IL194688A0 (en) | Rapid acting and long acting insulin combination formulations | |
| ZA200810323B (en) | Fkbp-l and uses thereof | |
| HRP20130109T1 (en) | Caspofungin formulations | |
| EP2062611A4 (en) | Microneedle and microneedle patch | |
| EP1887008A4 (en) | Thienotriazolodiazepine compound and a medicinal use thereof | |
| ZA200902161B (en) | Antiobodies and immunoconjugates and uses therefor | |
| IL194751A0 (en) | Drugs and uses | |
| HK1214181A1 (en) | A stable composition comprising pthrp and uses thereof pthrp | |
| PL2064327T3 (en) | Dbait and uses thereof | |
| HK1117082A1 (en) | A medicinal fatheadtree extract and preparation and use thereof | |
| HK1133552A1 (en) | Carboranylporphyrins and uses thereof | |
| IL197702A0 (en) | Anti-idiotype conjugate and its use as a standard in an immunassay | |
| EG25788A (en) | Artificial teethridge and fang | |
| EP2077262A4 (en) | Iminopyridine derivative and use thereof | |
| EP2113252A4 (en) | A forsythoside injection and preparation thereof | |
| IL195493A0 (en) | Combination preparations comprising bifeprunox and l-dopa | |
| GB0603717D0 (en) | Electricity-generate and store | |
| IL195532A0 (en) | Combination preparations comprising slv308 and a l-dopa | |
| ZA200810239B (en) | Combination preparations comprising SLV308 and a L-Dopa | |
| ZA200810238B (en) | Combination preparations comprising bifeprunox and L-DOPA | |
| GB2444960B (en) | Combined pseudoscope and hyperscope | |
| GB0621665D0 (en) | Blogmail and podmail | |
| GB2440379B (en) | Improvements In Software Distibution | |
| GB0608860D0 (en) | Order force effects and improved catalysis |